Founded in 2004, Diagenode is a multinational life science company that develops and commercializes innovative instruments and reagents for epigenetics, genomics and diagnostics. Diagenode has offices in Liège, Belgium and Denville, New Jersey. Diagenode is the only company providing a complete solution for epigenetics research, including state-of-the-art products and technologies for DNA sonication, best-in-class antibodies, and high-quality kits for chromatin immunoprecipitation (ChIP) and methylation studies (MeDIP and MethyCap). Recently, Diagenode has succesfully released automated epigenetics systems, the SX-8G and Compact IP-Star® automation platforms. Diagenode’s customers include leading epigenetics researchers, academic institutions, high-profile genome centers and pharmaceutical and biotechnology companies. Our high quality products allow scientists to produce consistent, cost-effective and robust results in their research. More: http://www.diagenode.com
In 2011, Dr. Hélène Pendeville was appointed as R&D Associate Scientist at Diagenode. Among others, she is in charge of the administrative and scientific follow-up of the EU projects in which Diagenode is involved. Dr. Pendeville performed her PhD thesis at the St. Jude Children’s Hospital in Mephis, TN and has a strong background in both epigenetics and development. Furthermore Dr. Pendeville has played a key role at the Molecular Biology and Genetic Engineering Department at the University of Liège.